Milestone Pharmaceuticals Inc.
10-K
March 20, 2026
Key Highlights
- U.S. FDA approval of CARDAMYSTβ’ (etripamil) in late 2024 for PSVT, making it the...
- Advanced Phase 3 clinical trials for etripamil in Atrial Fibrillation, targeting...
- Strategic international partnership with Corxel Pharmaceuticals for etripamil in...
Read Analysis
π€ AI Generated